March 4, 2016

No Image

Best of the Week: 'Spotlight' Wins Best Picture, 'Ghostbusters' Reboot Trailer Debuts and More

The Important News

The Oscars: Spotlight, Leonardo DiCaprio and Mad Max: Fury Road were among the big winners at the Academy Awards.

Star Wars Mania: Star Wars: The Force Awakens will hit digital then DVD/Blur-ray next month. Daisy Ridley is recording a song with Barbara Streisand. The creator of R2-D2 has died.

X-Movie X-Citement: Gambit has been delayed but Fox scheduled two more X-Men movies. Liev Shreiber has had talks about returning as Sabretooth in Wolverine 3.

Marvel Madness: Disney announced there will be no R-rated MCU movies. The Venom movie got a new writer.

DC Delirium: Suicide Squad 2 is already in the works. Batman v Superman: Dawn of Justice R-rated-cut content and deleted scenes were revealed.

Casting Net: Matthew McConaughey and Idris Elba have beenwere confirmed for The Dark Tower. Miles Teller and Josh Brolin will star in No Exit. Will Smith and Joel Edgerton will star in David Ayer’s Bright.

Franchise Fever: New Alien and Predator movies snagged release dates. James Bobin will direct the 21 Jump Street and Men in Black crossover.

New Directors New Films: Sam Raimi will direct World War 3. Zack Snyder wants to make a movie about George Washington. Jon Turteltaub will direct Meg. James Bobbin will direct the 21 Jump Street, Men In Black crossover.

Sequelitis: Tyler Hoechlin joined Fifty Shades Darker. Lee Toland Krieger may direct The Divergent Series: Ascendant. Surf’s Up is getting a sequel sub-titled WaveMania. Ariadna Gutierrez will play the love interest in xXx: The Return of Xander Cage.

Comedy Corner: The new Lonely Island movie finally got a title.

Remake Report: Diego Luna may join the Flatliners remake. Dakota Johnson and Tilda Swinton will star in a Suspiria remake. Takeshi ‘Beat’ Kitano will co-star in the live-action Ghost in the Shell.

First Look: The new Power Rangers unveiled a bunch of first-look images.

Box Office: Deadpool won another weekend.

Ride the Movie: Disney is moving forward on an It’s a Small World movie.

Reel TV: Big Hero 6 will continue as an animated TV series. David Hasselhoff will appear in the Baywatch movie.

Festival Fare: The 2016 Tribeca Film Festival announced a wave of titles.

The Videos and Geek Stuff

New Movie Trailers: Ghostbusters, Finding Dory, Ice Age: Collision Course, A Beautiful Planet, The Angry Birds Movie, Nina, Rio I Love You, The Man Who Knew Infinity and Louder Than Bombs.

TV Spot: The Divergent Series: Allegiant.

Clip: Batman v Superman: Dawn of Justice.

Watch: A fan recut of the Ghostbusters trailer.

See: New Batman v Superman: Dawn of Justice images. And Ben Affleck dressed up as Batman for kid’s birthday.

Watch: Oscars highlights and movie parodies. And two parodies of Oscar nominee Carol.

See: New Captain America: Civil War images. And new Captain America: Civil War promo posters.

Watch: Keanu Reeves training for John Wick 2.

See: Alternative costume designs for Deadpool. And a mashup of Deadpool and Back to the Future.

Watch: A mashup of Donald Trump and X-Men: Apocalypse. And the best mashup of everything ever.

See: Peter Mayhew’s proof that Han shot first in Star Wars.

Watch: Jurassic Park without the dinosaurs. And a supercut of Steven Spielberg’s most iconic shots.

See: This week’s best new movie posters.

Our Features

Monthly Movie Guide: Above is your guide to everything you need for the month of March.

Geek Movie Guide: How geek movies fared at the Oscars.

Sports Movie Guide: 6 movies about obscure sports.

Horror Movie Guide: Updates and news on horror sequels, remakes and more.

Comic Book Movie Guide: Captain America and Iron Man’s positions in Captain America: Civil War.

Filmmaker Guide: How many good movies does Paul Feig need to make before he’s trusted?

R.I.P.: Remembering George Kennedy and others who died in February.

Home Viewing: Here’s our guide to everything hitting VOD this week.

and

MORE FROM AROUND THE WEB:

This entry passed through the Full-Text RSS service – if this is your content and you’re reading it on someone else’s site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.


No Image

Tennis Writer And Commentator Bud Collins Dies

Venus Williams (left) and Serena Williams are interviewed by Bud Collins before the 2009 U.S. Open.

Venus Williams (left) and Serena Williams are interviewed by Bud Collins before the 2009 U.S. Open. Rob Tringali/Getty Images hide caption

toggle caption Rob Tringali/Getty Images

With his colorful style in both commentary and fashion, tennis writer and broadcaster Bud Collins livened up the tennis world for nearly 50 years. He died at his home in Brookline, Mass., at age 86.

His death was announced by his wife, Anita Ruthling Klaussen, on her Facebook page.

ARTHUR WORTH “BUD” COLLINS17 JUNE 1929 – 4 March 2016 Good night, sweet prince,And flights of angels sing thee to…

Posted by Anita Ruthling Klaussen on Friday, March 4, 2016

Collins, a longtime columnist for The Boston Globe and an analyst for CBS, NBC, ESPN and the Tennis Channel, was best known not only for his commentary during NBC’s Breakfast at Wimbledon broadcast live on weekend mornings but also for his lively pants and bow ties, sometimes yellow, sometimes purple, always vibrant.

In his remembrance of Collins, NPR’s Only A Game host Bill Littlefield wrote:

“He was almost as well-known for his sartorial splendor — more specifically for the gaudy pants that became a kind of trademark. In our conversation during the 2002 French Open, I mentioned to Bud that one of the players, Jeff Grant, had noted Bud’s trousers.

” ‘I think he had some kind of green and pink pastel with some flowers,’ Grant told me. ‘Vintage Bud.’

“I asked Bud for comment, and he responded, ‘I can categorically state that I have been paid by no one to wear anything. And no one would pay me to wear anything, and most people are surprised when I even pay for those creations.’ “

The pants were his “trademark and a symbol of the gusto he brought to his reporting,” NPR’s Tom Goldman reports.

“Collins wrote several tennis encyclopedia, and coached tennis at Brandeis University where one of his players was future activist Abbie Hoffman,” Tom says. “But it was his years of tennis columns and commentary that defined his career.”

The Globe wrote:

“In newspaper columns and as a TV commentator, Mr. Collins provided the sport with its most authoritative voice, and he also wrote a tennis encyclopedia and a history of the game, all while remaining one of the most congenial people anyone met courtside or in the press box.”

“Few people have had the historical significance, the lasting impact and the unqualified love for tennis as Bud Collins,” tennis legend Billie Jean King tweeted. “He was an outstanding journalist, an entertaining broadcaster and as our historian he never let us forget or take for granted the rich history of our sport. I will miss him and I will always cherish our memories of our journeys together.”

Few people have had the historical significance, lasting impact and the unqualified love for tennis as Bud Collins. pic.twitter.com/CLuJF2ThVm

— Billie Jean King (@BillieJeanKing) March 4, 2016

The New York Times wrote that “while he focused on tennis, he mused about anything that caught his eye” and covered combat in the Vietnam War. The paper adds:

“Mr. Collins was much the showman. He often quoted his imaginary Uncle Studley’s reflections on tennis. Steffi Graf was ‘Fraulein Forehand,’ Bjorn Borg was ‘the Angelic Assassin’ and the hard-serving Venus and Serena Williams were ‘Sisters Sledgehammer.’ He considered himself the representative of the everyday player, or the hacker, as he put it.”

Collins’ role as a tennis commentator had been limited in recent years as his health failed, but last year he attended the U.S. Open in New York, where the media center was dedicated and named in his honor.

Listen to NPR’s Only A Game host Bill Littlefield remember Collins on Here & Now.

This entry passed through the Full-Text RSS service – if this is your content and you’re reading it on someone else’s site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.


No Image

Action On A National GMO Labeling Measure Heats Up On Capitol Hill

A mockup of a possible GMO label on a can of Campbell’s Spaghetti-Os, with these words: “Partially produced with genetic engineering.” Lawmakers are scrambling to piece together a national GMO labeling standard before July 1. Courtesy of Campbell Soup Company hide caption

toggle caption Courtesy of Campbell Soup Company

With a July 1 deadline looming, Congress was scrambling this week to quickly set a national standard for labeling food products that contain genetically modified ingredients.

While most lawmakers mentioned polls showing the majority of Americans support GMO labeling, they differed on whether a national system should be voluntary or mandatory. A measure passed in the U.S. House last summer sets voluntary labeling standards.

The first mandatory GMO labeling law is set to go into effect in Vermont in July – Kansas Republican Sen. Pat Roberts has called it a “wrecking ball” headed the food industry’s way. Roberts, the chair of the Senate Agriculture, Nutrition and Forestry Committee, won first-round approval on Tuesday for his own GMO labeling bill – which would preempt Vermont’s law.

Roberts’ bill would create a voluntary USDA labeling standard for GMO foods. Perhaps more importantly, it specifically prevents states from creating their own labeling standards.

The labeling issue has created a conundrum for lawmakers. They must weigh the competing interests of activists who want more transparency in the food system, industrial agriculture, and large food companies, while also maneuvering the always-tricky issue of state rights. Pro-GMO forces worry that such labels would inherently imply that something is wrong with these foods.

Given the complicated dynamics involved, Sen. Heidi Heitkamp, a North Dakota Democrat, chastised her fellow committee members for passing the Roberts bill “in a pretty cavalier way.” Although she, too, voted for the measure, Heitkamp worried that the committee had essentially voted to “preempt a state law.” As she put it, lawmakers were telling Americans “we know better than they do” about their right to know what’s in their food.

“That’s a tough sell,” Heitkamp told her colleagues. “It’s a tough sell in a political environment where people think that Washington, D.C., doesn’t listen to them.”

Roberts’ bill now moves to the Senate floor, but he doesn’t believe he has the 60 votes needed to get it passed, so a compromise will have to be crafted.

Earlier this year, U.S. Agriculture Secretary Tom Vilsack oversaw negotiations on labeling rules between organic companies and conventional food manufacturers. But those talks broke down, and Vilsack said the issue is now in the hands of Congress.

Meanwhile, a competing labeling measure popped up this week: Democratic Sen. Jeff Merkley of Oregon introduced a bill that would make it mandatory for companies to disclose GMO ingredients as part of nutrition facts labels.

Campbell Soup Co., which announced in January that it would begin disclosing GMO ingredients on its products, applauded Merkley’s bill via Twitter.

We applaud @SenJeffMerkley on intro of #GMO nat’l labeling bill. Provides clear & consistent info consumers seek. https://t.co/MqGJCeqnce

— Campbell Soup Co (@CampbellSoupCo) March 2, 2016

“Provides clear & consistent info consumers seek,” the Tweet reads.

A fourth potential plan, a possible compromise from Sen. Joe Donnelly, an Indiana Democrat, was offered as an amendment during the ag committee meeting this week. It would create a voluntary disclosure program, which could become mandatory in three years if less than 85 percent of companies were listing GMO ingredients.

Donnelly characterized his plan as setting “ambitious goals” for companies to be more transparent.

“Instead of pitting conventional farmers versus organic [farmers], or concerned parents versus biotech companies, we need to quickly enact legislation that ensures consumers can get the information they want, without sticking misleading labels on every food product,” he told the committee.

This issue wasn’t so controversial in the House, where a voluntary labeling measure — sponsored by Kansas Republican Rep. Mike Pompeo — passed easily last July on a bipartisan vote of 275-150.

That both bills seeking a voluntary labeling system were sponsored by Republicans based in Midwest farm country shouldn’t come as a surprise. The majority of crops grown in the U.S. have been genetically engineered. According to the USDA, in 2015, 94 percent of soybean acreage and 92 percent of corn acreage are GE seeds.

And most of the large farm groups support Roberts’ bill, including the National Corn Growers and the American Soybean Association.

On the other side of the issue are environmentalists like Food & Water Watch and a group called Just Label It. They call Roberts’ and Pompeo’s bills the “Deny Americans the Right to Know” or DARK Act.


Peggy Lowe is investigations editor for Harvest Public Media and KCUR.

This entry passed through the Full-Text RSS service – if this is your content and you’re reading it on someone else’s site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.


No Image

Florida Doctor Says False Diagnoses Inflate Bills, Could Harm Patients

A federal whistleblower suit unsealed in late February alleges that Humana knew about billing fraud involving Medicare Advantage patients and didn't stop it.

A federal whistleblower suit unsealed in late February alleges that Humana knew about billing fraud involving Medicare Advantage patients and didn’t stop it. Ty Wright/Bloomberg via Getty Images hide caption

toggle caption Ty Wright/Bloomberg via Getty Images

Insurance giant Humana Inc., which operates some of the nation’s largest private Medicare health plans, knew for years of billing fraud at some South Florida clinics but did little to curb the practice even though it could harm patients, a doctor alleges in a newly unsealed whistleblower lawsuit.

The suit was filed by South Florida physician Mario M. Baez. It accuses Humana and Baez’s former business partner, Dr. Isaac K. Thompson, of engaging in a lucrative billing fraud scheme that lasted for years. The suit also names three other Palm Beach County doctors, two medical clinics and a doctors’ practice group as defendants. The suit was filed in October 2012 but remained under a federal court seal until Feb. 26.

Humana had no comment. “As a matter of long-standing company policy, Humana does not comment on pending litigation,” said company spokesman Tom Noland.

Thompson, a Delray Beach doctor, was indicted early last year on health care fraud charges stemming from similar allegations. He had pleaded not guilty but last week indicated he would change his plea and was to appear Friday in federal court in Fort Lauderdale, according to court records.

The Baez case is likely to bring fresh scrutiny to the giant Louisville, Ky.-based insurer, which covers more than 3 million elderly patients in its Medicare Advantage plans nationwide. The case could also spotlight costly flaws in the government’s complex and controversial method for paying private Medicare health plans.

The Baez suit targets a billing formula called a risk score, which is designed to pay Medicare health plans higher rates for sicker patients and less for people in good health. But overspending tied to inflated risk scores has cost taxpayers tens of billions of dollars in recent years, as the Center for Public Integrity reported in a series of articles published in 2014.

Federal officials have struggled for years to stamp out these overcharges, known in health care circles as “upcoding,” while at least a half-dozen whistleblowers have filed lawsuits accusing Medicare Advantage plans of ripping off the government.

Baez’s case adds a new wrinkle because it alleges that inflating risks scores not only wastes taxpayer dollars but can also cause a patient to be harmed by improper medical treatment.

Baez said in a letter to the presiding judge in the case, U.S. District Judge Kenneth A. Marra, that treating elderly patients with “multiple ailments” is difficult when you have accurate data, but “when medical records are poisoned with misleading data [from inflated risk scores] it becomes Russian roulette.” Patients aren’t told their risk score and aren’t likely to know if a doctor has exaggerated how sick they are or added bogus medical conditions to their medical records to boost profits, Baez said.

Baez and Thompson were partners in two clinics in Humana’s network, Lake Worth Medical P.A. and IM Medical P.A., in Delray Beach, from 2003 to 2012. Baez alleges in his suit that in February 2009 he became suspicious of billing practices at the two clinics and confronted doctors who worked there about it.

The doctors said they had been told by Thompson to “upcode” diagnoses, according to the suit. Baez said he reported the abuses to Humana in May 2009, but the company failed to return the alleged overpayments. In 2012, Baez contacted the FBI, which eventually sparked the Department of Justice criminal investigation that ensnared Thompson.

Doctors use a series of billing codes to document patients’ health, including any diseases they have and how severe they are. The Medicare Advantage plans report these codes to the government, which calculates a patient risk score and sends off a payment to the health plan.

In Thompson’s case, Humana paid 80 percent of the money it received to the doctor and retained the rest. Prosecutors charged that fraudulent diagnoses submitted by Thompson between January 2006 and June 2013 generated overpayments of $4.8 million.

Baez alleges that Humana encouraged overbilling by providing doctors in its network with forms that highlighted “more profitable” diagnosis codes they could use for patients. Many were statistically impossible to support, according to the suit, which cited allegedly inflated risk scores in more than three dozen patients.

For instance, scores of patients at IM Medical and Lake Worth Medical were diagnosed with a serious but rare spinal disorder called ankylosing spondylitis, when only 1 in 1,000 people truly has this disorder, according to Baez.

Similarly, aging patients with ordinary joint aches were diagnosed with “unspecified inflammatory polyarthropathy,” a chronic disease that requires the care of a specialist, according to the complaint.

Others with minor depression were said to have bipolar disorder, which paid the health plan a higher rate. According to the complaint, Humana officials agreed to fully correct the overages, but later “reneged” on the promise to do so and failed to correct the record with Medicare, according to Baez. The health plans are required to attest to the accuracy of any diagnoses submitted to the government.

The other doctors named as defendants in the Baez suit are Dennis Salazar, Arnaldo Mora and Daniela Mayer. All formerly worked for Thompson. The suit also named MCCI Group Holdings, a medical practice group. None of the doctors could be reached for comment. MCCI Group had no comment.

Humana has previously acknowledged it has been the target of investigations into its billing practices, including some involving whistleblowers. So has another large Medicare Advantage plan operated by UnitedHealth Group. Last month, UnitedHealth said it was cooperating with a Department of Justice review of its billing practices, according to a Securities and Exchange Commission filing.

Court filings unsealed in the Baez case confirm that the company faces several similar whistleblower suits, including at least one that remains under court seal. The court records also suggest that the criminal fraud investigation that snared Thompson is not over.

“There are some components of the criminal investigation which remain active,” Assistant U.S. Attorney Mark A. Lavine wrote in a December 2015 court filing. Lavine added that the investigation “continues to move forward aggressively.”

Lavine also indicated that two other whistleblower cases have been filed against Humana “in connection with similar allegations at other clinics.”

Baez told the center he has been frustrated with the plodding pace of the government investigations into Medicare Advantage. Keeping the matter under seal for so long “protects those who have perpetrated the fraud, but keeps patients and the public in the dark.”

In November 2015, Baez wrote to Marra asking that the seal be lifted.

“Seven years ago I presented to Humana the problem with upcoding and entering false information in patients’ medical records in order to justify the upcoding. … Nothing has changed. Nothing has been done to protect the hundreds of patients with misleading medical information in their medical records,” Baez wrote.

This piece comes from the Center for Public Integrity, a nonpartisan, nonprofit investigative news organization. For more, follow the center on Twitter @Publici, or sign up for its newsletter. Follow Fred Schulte: @FredSchulte

This entry passed through the Full-Text RSS service – if this is your content and you’re reading it on someone else’s site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.